These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

769 related items for PubMed ID: 32869941

  • 1. Analysis of immune-related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database.
    Hasegawa S, Ikesue H, Nakao S, Shimada K, Mukai R, Tanaka M, Matsumoto K, Inoue M, Satake R, Yoshida Y, Goto F, Hashida T, Nakamura M.
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1279-1294. PubMed ID: 32869941
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Neurological and related adverse events in immune checkpoint inhibitors: a pharmacovigilance study from the Japanese Adverse Drug Event Report database.
    Sato K, Mano T, Iwata A, Toda T.
    J Neurooncol; 2019 Oct; 145(1):1-9. PubMed ID: 31452071
    [Abstract] [Full Text] [Related]

  • 4. Pituitary-Related Adverse Events and Onset Patterns Caused by Immune Checkpoint Inhibitors: Analysis Using the Japanese Adverse Drug Event Report Database.
    Asano H, Noguchi Y, Kimura M, Usami E, Yoshimura T.
    Medicina (Kaunas); 2023 Nov 07; 59(11):. PubMed ID: 38004012
    [Abstract] [Full Text] [Related]

  • 5. Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System.
    Raschi E, Mazzarella A, Antonazzo IC, Bendinelli N, Forcesi E, Tuccori M, Moretti U, Poluzzi E, De Ponti F.
    Target Oncol; 2019 Apr 07; 14(2):205-221. PubMed ID: 30927173
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Renal adverse effects following the use of different immune checkpoint inhibitor regimens: A real-world pharmacoepidemiology study of post-marketing surveillance data.
    Chen G, Qin Y, Fan QQ, Zhao B, Mei D, Li XM.
    Cancer Med; 2020 Sep 07; 9(18):6576-6585. PubMed ID: 32720449
    [Abstract] [Full Text] [Related]

  • 9. Immune checkpoint inhibitors-related myocarditis in patients with cancer: an analysis of international spontaneous reporting systems.
    Ma R, Wang Q, Meng D, Li K, Zhang Y.
    BMC Cancer; 2021 Jan 07; 21(1):38. PubMed ID: 33413213
    [Abstract] [Full Text] [Related]

  • 10. Hepatic failure associated with immune checkpoint inhibitors: An analysis of the Food and Drug Administration Adverse Event Reporting System database.
    Xu Y, Yan C, Zhao Y, Li D, Guo M, Cui X.
    Cancer Med; 2023 Apr 07; 12(8):9167-9174. PubMed ID: 36734333
    [Abstract] [Full Text] [Related]

  • 11. Nephrotoxicity of immune checkpoint inhibitor therapy: a pharmacovigilance study.
    Haeuser L, Marchese M, Cone EB, Noldus J, Bayliss G, Kilbridge KL, Trinh QD.
    Nephrol Dial Transplant; 2022 Jun 23; 37(7):1310-1316. PubMed ID: 34028534
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bone fracture as a novel immune-related adverse event with immune checkpoint inhibitors: Case series and large-scale pharmacovigilance analysis.
    Filippini DM, Gatti M, Di Martino V, Cavalieri S, Fusaroli M, Ardizzoni A, Raschi E, Licitra L.
    Int J Cancer; 2021 Aug 01; 149(3):675-683. PubMed ID: 33844854
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immune checkpoint inhibitor-induced pure red cell aplasia: Case series and large-scale pharmacovigilance analysis.
    Guo Q, Gao J, Guo H, Xie J, Cheng J.
    Int Immunopharmacol; 2023 Jan 01; 114():109490. PubMed ID: 36459923
    [Abstract] [Full Text] [Related]

  • 17. Neuroimmunological adverse events associated with immune checkpoint inhibitor: a retrospective, pharmacovigilance study using FAERS database.
    Mikami T, Liaw B, Asada M, Niimura T, Zamami Y, Green-LaRoche D, Pai L, Levy M, Jeyapalan S.
    J Neurooncol; 2021 Mar 01; 152(1):135-144. PubMed ID: 33423151
    [Abstract] [Full Text] [Related]

  • 18. The association of hypophysitis with immune checkpoint inhibitors use: Gaining insight through the FDA pharmacovigilance database.
    Tang Q, Han Y, Song M, Peng J, Zhang M, Ren X, Sun H.
    Medicine (Baltimore); 2024 Mar 29; 103(13):e37587. PubMed ID: 38552079
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.